Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Research confirms the Lumipulse serum p-tau217 assay's effectiveness in diagnosing Alzheimer's, paving the way for accessible ...

The promising test zeroes in on a biomarker in the blood, called phospho-tau217 (p-tau217). Scientists have discovered that ...

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

Ellen’s experience highlights the growing promise of blood-based testing for Alzheimer’s. By identifying disease-specific biomarkers in the bloodstream, these tests offer a minimally invasive ...

Researchers developing benchmarks for a blood-based test like those for measuring blood glucose and cholesterol ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...

Alzheimer’s blood tests are the key to widespread prevention of dementia, experts say. If people can be diagnosed in their doctor’s office, they can more immediately move into preventive care ...

This was from the pioneering work of Oskar Hansson and colleagues from the University of Lund in Sweden, demonstrating in multiple cohorts how this biomarker discriminated Alzheimer’s disease (AD) ...